NephRx Corporation announced the issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
Pozen Inc. announced a deal with Johnson & Johnson's Cilag GmbH International division to make and sell its migraine drug in South America. Pozen said Cilag will sell its drug, MT 400, in Brazil, Colombia, Ecuador and Peru.
OMS302 is Omeros' pharmacosurgery product in development to maintain intra-operative mydriasis (pupil dilation) and reduce postoperative pain and irritation resulting from cataract and other lens replacement surgery.
Hi-Tech Pharmacal Co., Inc. announced that the U.S. Food and Drug Administration, granted final approval for its Abbreviated New Drug Application, for ranitidine syrup 15mg/mL, the generic for GlaxoSmithKline's Zantac syrup.
The RingDex is a filling system with a unique modular design that will greatly improve previously manual & tedious filling / capping operations. Unlike traditional filling systems, the RingDex allows quick changeovers for low to medium volume production.
The INTEGRA VIAFLO 96 is a 96-channel electronic pipette that enables fast, precise and easy simultaneous transfer of 96 samples. The VIAFLO 96 has been designed to be used just like a standard handheld pipette.
Supercritical Fluid Technologies introduces a benchtop supercritical fluid extractor, the SFT-110XW. The completely redesigned restrictor valve with integrated micrometer allows for very precise flow control, which is essential for demanding applications.
The MiniVap Blowdown Evaporator from Porvair Sciences takes just minutes to remove volatile organic solvents from your HPLC fractions collected in 24- or 96-well microplates.
Merck KGaA announced that it has entered into a definitive agreement to acquire the microbiology business of Biotest AG. The business has approximately 290 employees and sales of approximately €50 million in 2010.
Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca’s chemical compound library to identify those which trigger a key element of cancer cell ageing – called senescence.
Provectus Pharmaceuticals, Inc. has held its second end-of-Phase 2 meeting with the U.S. Food and Drug Administration. The meeting addressed the company’s planned pivotal Phase 3 randomized controlled trial of PV-10 for metastatic melanoma.
Bristol-Myers Squibb Co. said that a new study of its highly anticipated melanoma drug improved survival time in patients with advanced skin cancer.
Cephalon Inc. said it will acquire privately held Gemin X Pharmaceuticals Inc. for $225 million in an all-cash deal aimed at bolstering Cephalon's lineup of cancer treatments.
Drugmakers Merck & Co. and Sanofi-Aventis SA on abandoned a year-old effort to create a veterinary medicine joint venture because of the deal's mounting complexity and regulatory hurdles.
A paper detailing an important discovery in Niemann-Pick Type C shows how use of a histone deacetylase inhibitor corrects the damage done by the genetic disorder and allows once-diseased cells to function normally.